From a potential mechanistic point of view, our studies indicate that the effects of blocking PD-1/PD-L1 interactions, thereby improving the immunological response [7, 8], may have resulted from increased activation of TILs rather than changes in the number of cells infiltrating the tumor. Here, CD274 is linked to neoplasm.